Antibodies

Explore the CRG Antibodies database

CRG has designed and produced more than 200 monoclonal and polyclonal antibodies against transcription factors (TF) and centrosomal proteins. The selected TF are tissue-specific and have an ortholog in mouse. Learn More / Less

For the prediction of the antigenic determinant we developed a software method (GOLDQUEST) which accounts for the unstructured protein regions as well as other physico-chemical properties of the protein in order to determine epitopes suitable for antibody generation. Three peptides have been selected per protein and the sequences are unique in the human genome.
Below you can find all the targets against which antibodies have been developed and their availability, information about recognition on western blotting or reagents and tools.

ENSEMBL IDs	CATEGORY	Gene Name	Availability Polyclonals	Availability Monoclonals
ENSG00000166478	Transcription factors	ZNF143	YES	In process
ENSG00000140548	Transcription factors	ZNF710	YES	In process
ENSG00000100968	Transcription factors	NFATC4	YES	In process
ENSG00000104447	Transcription factors	TRPS1	YES	In process
ENSG00000100625	Transcription factors	SIX4	YES	In process
ENSG00000052850	Transcription factors	ALX4	YES	In process
ENSG00000109101	Transcription factors	FOXN1	YES	In process
ENSG00000106031	Transcription factors	HOXA13	YES	In process
ENSG00000067082	Transcription factors	KLF6	YES	In process
ENSG00000109705	Transcription factors	NKX3-2	YES	In process
ENSG00000105967	Transcription factors	TFEC	YES	In process
ENSG00000163539	Transcription factors	CLASP2	YES	In process
ENSG00000237649	Transcription factors	HSET	YES	In process
YGR037C	Transcription factors	ACB1	YES	In process
YLL050C	Transcription factors	COF1	YES	In process
ENSG00000122592	Transcription factors	HOXA7	YES	In process
ENSG00000105516	Transcription factors	DBP	YES	In process
ENSG00000168267	Transcription factors	PTF1A	YES	In process
ENSMUSG00000042500	Transcription factors	mAgo4	YES	In process
ENSG00000029153	Transcription factors	ARNTL2	YES	In process